Advertisement · 728 × 90
#
Hashtag
#CGTS
Advertisement · 728 × 90
Post image

🟢 Día Mundial del Clima

Es momento de impulsar una transición justa que no deje a nadie atrás, integrando sostenibilidad, derechos y bienestar colectivo.

#CGTS #TrabajoSocial #DíaMundialdelClima #EconomíaSostenible #MedioAmbiente

0 0 0 0
Preview
32-34 NEW PHARMA - In therapies PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat...

#obesity #diabetes #typeIIdiabetes #oncology #neurology #rarediseases #womenshealth #EliLilly #Akeso #SummitTherapeutics #precisionmedicine #immunotherapy #Alzheimersdisease #AstraZeneca #DaiichiSankyo #ADCs #precisiononcology #DrugstoWatch2026 #immunology #cardiology #CGTs
zurl.co/c8PJw

5 0 1 0
Post image

🟢Premio Estatal del Trabajo Social 2026:

Desde el #CGTS nos alegra anunciar que la Trabajadora Social Miren Koldobike Velasco recibirá el PREMIO ESTATAL DE TRABAJO SOCIAL 2026 en la categoría de Profesión.

¡Enhorabuena compañera!

1 1 0 0
Post image

🟢¡Únete a nuestro canal de WhatsApp y no te pierdas ninguna novedad!

#CGTS #CGTrabajoSocial

0 0 0 0
Post image

¡Escudo social, sí!

🟢El #CGTS se ha posicionado en la defensa del Escudo Social, tras la no aprobación en el Congreso de las medidas vinculadas a su prórroga.

Lee la noticia completa y el manifiesto aquí:

www.cgtrabajosocial.es/noticias/rec...

#Trabajosocial #escudosocialsí #nodejaranadieatrás

1 0 0 0
Post image

🟢El #CGTS participa en el I Congreso multisede sobre servicios sociales, cuidados y comunidad “Los cuidados que queremos”, organizado por el Ministerio de Derechos Sociales, Consumo y Agenda 2030 siendo parte del Comité Científico, y contribuyendo al diseño y orientación de los contenidos.

1 0 0 0
Post image

🟢 El #CGTS participa en la validación del modelo CoSSer de coordinación sociosanitaria impulsado por la Federación Española de Párkinson.

🟢 Accede a la noticia: www.cgtrabajosocial.es/noticias/el-...

#TrabajoSocial #CoordinaciónSociosanitaria #Párkinson #AtenciónIntegral #CoSSer

1 0 0 0
Post image

🟢04 de Febrero: Día Mundial Contra el Cáncer.
"La prevención, el diagnóstico precoz y la investigación siguen siguendo claves para reducir la mortalidad por cáncer" (SEOM - @seom_oncologia)
#TrabajoSocial #CGTS #DíaMundialContraElCancer

1 0 0 0
Preview
How digital can ease the burden of cell and gene therapy long-term follow-up Because CGTs are designed to have lasting and lifelong effects, regulatory bodies often mandate 15-year, long-term follow-up. Fortunately, collaborative groups are creating resources and recommendatio...

Because #CGTs are designed to have lasting and lifelong effects, regulatory bodies often mandate 15-year, long-term follow-up. LTFU allows the industry to uncover potential delayed or rare side effects while measuring the durability of treatment, making the treatment better understood and safer.🧪🧬⑂

0 1 0 0
Post image

ASGCT appreciates Senate appropriators for their bipartisan leadership in advancing #CGTs. The $400M NIH increase and strong CGT support in the FY26 Labor-HHS bill reflect a shared commitment to transforming patient care through innovative science. #ASGCTadvocacy

0 0 0 0
Preview
Cell and gene therapies: Stagnation or maturation? Despite questions around stagnation, experts argue that cell and gene therapies are evolving rapidly –driven by innovation in manufacturing, decentralisation, and targeted delivery. Nicole Raleigh gat...

#Cellandgenetherapies #CGTs #CARTs #FDA #cellandgeneandtissuetherapies #CARTcelltherapies #AAV #autologousCARTtherapies #CD19 #BCMA #REMS #celltherapytechnologies #AnthonyNolan #CARTworkflow #Vertex #bluebirdbio #eXmoorPharma #CGTindustry #personalisedtreatment
pharmaphorum.com/deep-dive/ce...

0 0 0 0
CBER head Vinay Prasad resigns amid controversy Prasad, tangled in a public dispute with Sarepta, has left the FDA after less than three months as director of CBER.

Vinay Prasad has left the #FDA after less than three months as director of #CBER, a government spokesperson confirmed to media outlets late Tuesday. In addition to regulating #vaccines and #CGTs, Prasad was also the FDA's chief medical and scientific officer. 🧪🧬⑂

3 3 1 0
Post image

How Strategic Planning Shapes Successful Cell & Gene Therapy Launches. Learn more here: firstwordpharma.com/navigating-l...

Brought to you by #UnipharGroup

#biopharma #biotechnology #celltherapy #CGTs #druglaunch #genetherapy #pharmaceuticals #rarediseases #regulatoryaffairs

0 0 0 0
Post image

Making CGTs Work Worldwide: Key Barriers and Enablers in Global Access and Distribution. Learn more here: firstwordpharma.com/current-cgt-...

Brought to you by #UnipharGroup

#biopharma #biotechnology #celltherapy #CGTs #drugdevelopment #genetherapy #pharmaceuticals #rarediseases #regulatoryaffairs

0 0 0 0
Post image

From Rare to Routine: What’s Driving the Next Phase of Cell and Gene Therapy Growth. Learn more here: firstwordpharma.com/current-cgt-...

Brought to you by #UnipharGroup

#biopharma #biotechnology #celltherapy #CGTs #drugdevelopment #genetherapy #pharmaceuticals #rarediseases #regulatoryaffairs

0 0 0 0
Preview
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser) In this short teaser, BioSpace's Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upc...

For those heading to #JPM2025, here is a little teaser of ehat to expect from #petermarks and #tomwhitehead at the GenScript Biotech Forum 2025 about the future of #CGTs

www.biospace.com/business/a-c...

0 1 0 0
President-Elect Terry Flotte, MD, is attending the #WhiteHouseCGT forum Jan. 8.

President-Elect Terry Flotte, MD, is attending the #WhiteHouseCGT forum Jan. 8.

This afternoon on behalf of ASGCT, President-Elect Terry Flotte, MD, is attending the #WhiteHouseCGT forum! Organized by @the-white-house.bsky.social OSTP, speakers will cover challenges + opportunities in #CGTs, regulatory approaches, the patient perspective, + more!

3 0 0 0